SCHEMBL26550888

SCHEMBL26550888

CCC(C)C(=O)CNC(=O)C1CSc2c(F)c(F)c(c(F)c2F)-c2c(F)c(F)c(c(F)c2F)SCC(NS)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)N1

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ LDHB P07195 1/20 0.39
▸ NNMT P40261 2/20 0.36
▸ KLKB1 P03952 5/20 0.35
▸ KEAP1 Q14145 2/20 0.35
▸ PLAU P00749 3/20 0.34
▸ MC4R P32245 1/20 0.34
▸ MC5R P33032 1/20 0.34
▸ MC3R P41968 1/20 0.34
▸ MC1R Q01726 1/20 0.34
▸ CTSG P08311 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ F12 P00748 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26550424 0.98 LDHB (0.40) LDHBNNMTKLKB1KEAP1PLAU
SCHEMBL26549275 0.94 LDHB (0.38) LDHBNNMTKLKB1KEAP1PLAU
SCHEMBL26548790 0.94 LDHB (0.38) LDHBNNMTKLKB1KEAP1PLAU
SCHEMBL26549444 0.91 LDHB (0.39) LDHBNNMTKLKB1KEAP1PLAU
SCHEMBL26548683 0.91 LDHB (0.39) LDHBNNMTKLKB1KEAP1PLAU
SCHEMBL26549320 0.91 LDHB (0.39) LDHBNNMTKLKB1KEAP1PLAU
SCHEMBL27005370 0.91 LDHB (0.39) LDHBNNMTKLKB1KEAP1PLAU
SCHEMBL26549219 0.91 LDHB (0.39) LDHBNNMTKLKB1KEAP1PLAU
SCHEMBL26549679 0.89 LDHB (0.36) LDHBNNMTKLKB1KEAP1PLAU
SCHEMBL20442198 0.87 LDHB (0.36) LDHBNNMTKLKB1KEAP1PLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4306538-A2 PEPTIDE OLIGONUCLEOTIDE CONJUGATES Sarepta Therapeutics, Inc. (US) 2024-01-17 — — EP disclosed
EP-3297649-B1 PEPTIDE OLIGONUCLEOTIDE CONJUGATES SAREPTA THERAPEUTICS INC (US) 2023-10-11 — — EP disclosed
Send feedback